Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery

FEBS Letters

Volumn 531, Issue 1, 2002, Pages 23-27

  Jorgensen, Kent ^a   Davidsen, Jesper ^a   Mouritsen, Ole G ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anti cancer drug; Lipid domain; Phospholipase A2; Pro drug; Pro enhancer; Stealth liposome

Indexed keywords

LIPOSOME; PHOSPHOLIPASE A2; VENOM;

ABSORPTION; BIOPHYSICS; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; LIPID BILAYER; PANCREAS; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; BIOPHYSICS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; HUMANS; LIPID BILAYERS; LIPIDS; LIPOSOMES; MICELLES; MODELS, CHEMICAL; PHOSPHOLIPASES A; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TEMPERATURE; TIME FACTORS;

EID: 0037201946     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03408-7     Document Type: Short Survey

References (44)

1. Berg O.G., Gelb M.H., Tsai M.-D., Jain M.K. Chem. Rev. 101:2001;2613-2653.
2. Six D.A., Dennis E.A. Biochim. Biophys. Acta. 1488:2000;1-19.
3. Hønger T., Jørgensen K., Biltonen R.L., Mouritsen O.G. Biochemistry. 35:1996;9003-9006.
4. Bell J.D., Biltonen R.L. Methods Enzymol. 197:1991;249-258.
5. Hønger T., Jørgensen K., Stokes D., Biltonen R.L., Mouritsen O.G. Methods Enzymol. 286:1997;168-190.
6. Nielsen L.K., Bjørnholm T., Mouritsen O.G. Nature. 404:2000;352.
7. Nielsen L.K., Vishnyakov A., Jørgensen K., Bjørnholm T., Mouritsen O.G. J. Phys. Condens. Matter. 12:2000;309-314.
8. Kaasgaard T., Leidy C., Ipsen J.H., Mouritsen O.G., Jørgensen K. Single Mol. 2:2001;105-108.
9. Høyrup P., Jørgensen K., Mouritsen O.G. Europhys. Lett. 57:2002;464-470.
10. Nielsen L.K., Risbo J., Callisen T.H., Bjørholm T. Biochim. Biophys. Acta. 1420:1999;266-271.
11. Kaasgaard T., Ipsen J.H., Mouritsen O.G., Jørgensen K. J. Probe Microsc. 2:2001;169-175.
12. Høyrup P., Mouritsen O.G., Jørgensen K. Biochim. Biophys. Acta. 1515:2001;133-143.
13. Vermehren C., Keibler T., Hylander I., Callisen T.H., Jørgensen K. Biochim. Biophys. Acta. 1373:1998;27-36.
14. Jørgensen K., Vermehren C., Mouritsen O.G. Pharm. Res. 16:1999;1493-1495.
15. Andresen T.L., Mouritsen O.G., Begtrup M., Jørgensen K. Biophys. J. 82:2002;148a.
16. Davidsen J., Mouritsen O.G., Jørgensen K. Biochim. Biophys. Acta. 1564:2002;256-262.
17. Jørgensen, K., Davidsen, J., Vermehren, C., Frøkjær, S. and Mouritsen, O.G. (patent pending WO 01/58910).
18. Davidsen, J., Jørgensen, K., Andresen, T.L. and Mouritsen, O.G. (2002) Biochim. Biophys. Acta, submitted.
19. Mouritsen O.G., Jørgensen K. Curr. Opin. Struct. Biol. 7:1997;518-527.
20. Jacobson K., Dietrich C. Trends Cell Biol. 9:1999;87-91.
21. Mouritsen O.G., Jørgensen K. Pharm. Res. 15:1998;1507-1519.
22. Leidy C., Wolkers W.F., Mouritsen O.G., Jørgensen K., Crowe J.H. Biophys. J. 80:2001;1819-1828.
23. Bagatolli L., Gratton E. Biophys. J. 78:2000;290-305.
24. Dietrich C., Yang B., Fujiwara T., Kusumi A., Jacobson K. Biophys. J. 82:2002;274-284.
25. Gliss G., Clausen-Schaumann H., Günther R., Odenbach S., Randl O., Bayler T.M. Biophys. J. 74:1998;2443-2450.
26. Rinia H.A., de Kruijff B. FEBS Lett. 504:2001;194-199.
27. Kaasgaard T., Mouritsen O.G., Jørgensen K. FEBS Lett. 515:2002;29-34.
28. Burack W.R., Dibble A.R., Alietta M.M., Biltonen R.L. Biophys. J. 36:1997;10551-10557.
29. Grainger D.W., Reichert A., Ringsdorf H., Salesse C. FEBS Lett. 252:1989;72-82.
30. Burack W.R., Biltonen R.L. Chem. Phys. Lipids. 73:1994;209-222.
31. Sanchez S.A., Bagatolli L.A., Gratton E., Hazlett T.L. Biophys. J. 82:2002;2232-2243.
32. Lehtonen J.Y.A., Kinnunen P.K.J. Biophys. J. 68:1995;1888-1894.
33. Lasic, D.D. and Martin, F. (Eds.) (1995) Stealth Liposomes, CRC, Boca Raton, FL.
34. Epand, R. (Ed.) (1996) Chem. Phys. Lipids 81, 101-255.
35. Needham D., Anyarambhatla G., Kong G., Dewhirst M.W. Cancer Res. Adv. Brief. 60:2000;1197-1201.
36. Meers P. Adv. Drug Deliv. Rev. 53:2001;265-272.
37. Lasic D.D., Needham D. Chem. Rev. 95:1995;2601-2628.
38. Blume G., Cevc G. Biochim. Biophys. Acta. 1146:1993;157-168.
39. Gabizon, A. and Barenholtz, Y. (1999) in: Liposomes: Rational Design (Janoff, A., Ed.), Marcel Dekker, New York, pp. 343-362.
40. Torcilin V.P., Herron J.N., Gentry C.A. Biochim. Biophys. Acta. 1195:1994;11-20.
41. Lohmeyer M., Workman P. Br. J. Cancer. 72:1995;277-286.
42. Abe T., Sakamoto K., Kamohara H., Hirano Y., Kuwahara N., Ogawa M. Int. J. Cancer. 74:1997;245-250.
43. Yamashita S., Ogawa M., Sakamoto K., Abe T., Arakawa H., Yamashita J. Clin. Chem. Acta. 228:1994;91-99.
44. Kaiser E. Crit. Rev. Clin. Lab. Sci. 36:1999;65-163.